Subsequently, mean serum PRL levels in the BC, IDP, and NNL groups showed no significant difference, whereas the mean serum PRL levels were significantly different between FET and NNL patients (25.93 ng/mL vs. 21.42 ng/mL, p < 0.05, Figure 2B). Here, PRL is linked to breast cancer.